Detalles de la búsqueda
1.
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020.
J Natl Compr Canc Netw
; 18(1): 12-22, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31910384
2.
Dose capping of plerixafor in patients weighing more than 100 kg at one vial led to successful mobilization outcomes and significant cost savings.
Transfusion
; 58(2): 323-329, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134662
3.
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(12): 1520-1541, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29223990
4.
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(2): 268-276, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26325438
5.
Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
Support Care Cancer
; 23(11): 3141-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25791390
6.
Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization.
Transfusion
; 54(8): 2015-21, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24660786
7.
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
Biol Blood Marrow Transplant
; 19(2): 298-304, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23078784
8.
Pharmacoeconomics of hematopoietic stem cell mobilization: an overview of current evidence and gaps in the literature.
Biol Blood Marrow Transplant
; 19(9): 1301-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23685251
9.
Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.
Biol Blood Marrow Transplant
; 19(4): 509-18, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23419976
10.
Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent.
Transfusion
; 53(12): 3244-50, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23607889
11.
Myeloid growth factors.
J Natl Compr Canc Netw
; 11(10): 1266-90, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24142827
12.
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
Blood
; 115(5): 1098-105, 2010 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19965688
13.
Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.
Ther Drug Monit
; 32(6): 680-7, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20864900
14.
Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia.
Leuk Lymphoma
; 60(5): 1187-1192, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30322332
15.
Management of drug interaction between posaconazole and sirolimus in patients who undergo hematopoietic stem cell transplant.
Pharmacotherapy
; 35(6): 578-85, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26037821
Resultados
1 -
15
de 15
1
Próxima >
>>